Nuclear detonation, thyroid cancer and potassium iodide prophylaxis

The recent nuclear disaster at Japan has raised global concerns about effects of radioactive leakage in the environment, associated hazards, and how they can be prevented. In this article, we have tried to explain about the guidelines laid down by World Health Organization for a potassium iodide pro...

Full description

Bibliographic Details
Main Author: Wiwanitkit, Viroj
Format: Online
Language:English
Published: Medknow Publications 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125013/
id pubmed-3125013
recordtype oai_dc
spelling pubmed-31250132011-07-01 Nuclear detonation, thyroid cancer and potassium iodide prophylaxis Wiwanitkit, Viroj Review Article The recent nuclear disaster at Japan has raised global concerns about effects of radioactive leakage in the environment, associated hazards, and how they can be prevented. In this article, we have tried to explain about the guidelines laid down by World Health Organization for a potassium iodide prophylaxis following a nuclear disaster, and its mechanism of action in preventing thyroid cancer. Data was collected mainly from the studies carried out during the Chernobyl disaster of Russia in 1986 and the hazardous effects especially on the thyroid gland were studied. It was seen that radioactive iodine leakage from the nuclear plants mainly affected the thyroid gland, and especially children were at a higher risk at developing the cancers. Potassium Iodide prophylaxis can be administered in order to prevent an increase in the incidence of thyroid cancers in the population of an area affected by a nuclear disaster. However, one has to be cautious while giving it, as using it without indication has its own risks. Medknow Publications 2011 /pmc/articles/PMC3125013/ /pubmed/21731865 http://dx.doi.org/10.4103/2230-8210.81937 Text en © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Wiwanitkit, Viroj
spellingShingle Wiwanitkit, Viroj
Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
author_facet Wiwanitkit, Viroj
author_sort Wiwanitkit, Viroj
title Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
title_short Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
title_full Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
title_fullStr Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
title_full_unstemmed Nuclear detonation, thyroid cancer and potassium iodide prophylaxis
title_sort nuclear detonation, thyroid cancer and potassium iodide prophylaxis
description The recent nuclear disaster at Japan has raised global concerns about effects of radioactive leakage in the environment, associated hazards, and how they can be prevented. In this article, we have tried to explain about the guidelines laid down by World Health Organization for a potassium iodide prophylaxis following a nuclear disaster, and its mechanism of action in preventing thyroid cancer. Data was collected mainly from the studies carried out during the Chernobyl disaster of Russia in 1986 and the hazardous effects especially on the thyroid gland were studied. It was seen that radioactive iodine leakage from the nuclear plants mainly affected the thyroid gland, and especially children were at a higher risk at developing the cancers. Potassium Iodide prophylaxis can be administered in order to prevent an increase in the incidence of thyroid cancers in the population of an area affected by a nuclear disaster. However, one has to be cautious while giving it, as using it without indication has its own risks.
publisher Medknow Publications
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125013/
_version_ 1611462646686547968